People in the top nine priority groups outlined by the Joint Committee on Vaccination and Immunisation (JCVI) have now been offered their first Covid vaccine. More than 32 million people have received their first vaccine dose in the UK to date, while approximately eight million people have also received their second vaccine dose.
Which Covid vaccine will the over-45’s get?
People over the age of 45 are now being invited to book their Covid vaccine appointments.
Three Covid vaccines have been approved for use in the UK from Pfizer/BioNTech, Oxford/AstraZeneca and Moderna.
The first Moderna vaccines have started to be rolled out in recent weeks, but the majority of vaccines given out in the UK to date are from Pfizer/BioNTech or AstraZeneca.
This group will be followed by those aged 30-39 and then those in the 18-29 age bracket.
With several Covid vaccines currently still being investigated, new Covid vaccines could be rolled out to the rest of the population over the coming months.
The Novavax vaccine has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) yet, but it is expected to be approved soon as early results show the vaccine to be safe and effective.
The UK has secured 60 million Novavax doses, along with other vaccine doses including Valneva (100 million), Janssen (30 million) and GlaxoSmithKline (60 million).